Changes in immune pathways, inflammatory processes, and cell adhesion molecules may underlie the pathogenesis of both diseases, and ERRFI1 may be a potential diagnostic marker for patients with OSA and AS. The gene discussed is ERRFI1; the disease is obstructive sleep apnea syndrome.